心肌梗死后心脏胶原重塑的意义及干预研究
被引量：5
摘要
心肌梗死后心脏发生修复性纤维化和反应性纤维化等胶原重塑改变 ,参与心力衰竭的发生、发展。针对病理性胶原重塑的深入研究为防治心肌梗死后心力衰竭的发生、发展开辟了新的思路。
出处
《中国循环杂志》
CSCD
北大核心
2003年第6期474-475,共2页
Chinese Circulation Journal
参考文献15
-
1[1]Murakami M, Kusachi S, Nakahama M, et al. Expression of the alpha 1 and alpha 2 chains of type Ⅳ collagen in the infarct zone of rat myocardial infarction. J Mol Cell Cardiol, 1998, 30: 1191-1202.
-
2[2]Campbell SE, Janicki JS, Weber KT. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin Ⅱ or aldosterone. J Mol Cell Cardiol, 1995,27: 1545-1560.
-
3[3]SanoH, OkamotoH, KitabatakeA, et al. Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats. Mol Cell Biochem, 1998, 178: 51-58.
-
4[4]Sun Y, Zhang JQ, Zhang J, et al. Angiotensin Ⅱ, transforming growth factor-betal and repair in the infarcted heart. J Mol Cell Cardiol, 1998, 30: 1559-1569.
-
5[5]Brilla CG, Maisch B, Rupp H, et al. Pharmacological modulation of cardiac fibroblast function. Herz, 1995, 20: 127-134.
-
6[6]Tsutamoto T, Wada A, Maeda K, et al. Transcardiac extraction of circulating endothelin-1 across the failing heart. Am J Cardiol, 2000, 86:524-528.
-
7[7]Bahai P, Pechanova O, Bernatova I, et al. Chronic inhibition of NOsynthesis produces myocardial fibrosis and arterial media hyperplasia.Histol Histopathol, 1997, 12: 623-629.
-
8[8]Raya TE, Gaballa M, Anderson P, et al. Left ventricular function and remodeling after myocardial infarction in aging rats. Am J Physiol,1997, 273: H2652-H2658.
-
9[9]Yu CM, Tipoe GL, Wing-Hon Lai K, et al. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflmtory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol, 2001, 38:1207-1215.
-
10[10]Seeland U, Kouchi I, ZolkO, et al. Effect of ramipriland furosemidetreatment on interstitial remodeling in post-infarction heart failure rat hearts. J Mol Cell Cardiol, 2002, 34: 151-163.
同被引文献22
-
1MinLi Geng-TaoLiu.Inhibition of Fas/FasL mRNA expression and TNF-a release in concanavalin A-induced liver injury in mice by bicyclol[J].World Journal of Gastroenterology,2004,10(12):1775-1779. 被引量：23
-
2李丹,范哲,李广生.心肌纤维化的调控因素[J].心血管病学进展,2004,25(4):253-257. 被引量：24
-
3李秀昌,李素梅,张运,张梅,王荣,胡燕燕.三维超声心动图评价心肌梗死患者左室局部心功能[J].中国超声医学杂志,2005,21(4):270-273. 被引量：15
-
4杨文奇,毛淑丹,陶贵周.急性心肌梗塞后左心室重构的研究现状[J].中国误诊学杂志,2005,5(10):1821-1823. 被引量：9
-
5DING B, PRICE R L, GOLDSMITH E C, et al. Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure[J].Circulation, 2000, 101: 2854-2862.
-
6SAHLGREN B, EKLOF A C, APERIA A. Studies of the renal component of the hypertension in rats with aortic constriction. Role of angiotensin Ⅱ [J].Acta Physiol Scand, 1986, 127: 443-448.
-
7OGATA T, MIYAUCHI T, SAKAI S, et al. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway[J]. J Am Coll Cardiol, 2004,43: 1484-1488.
-
8OGATA T, MIYAUCHI T, SAKAI S, et al. Stimulation of peroxisome-proliferator-activated receptor alpha (PPAR alpha) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts[J]. Clin Sci (Lond), 2002, 103: 284-288.
-
9CHEN K, CHEN J, LI D, et al. Angiotensin Ⅱ regulation of collagen type Ⅰ expression in cardiac fibro-blasts: modulation by PPAR-gamma ligand pioglitazone[J]. Hypertension, 2004, 44: 655-661.
-
10Phatharajaree W, Phrommintikul A, Chattipakom N, et al. Matrix metalloproteinases and myocardial infarction[J]. Can J Cardiol, 2007, 23(9): 727-733.
引证文献5
-
1刘桂兰.心肌梗死左心室改变及左心功能的彩超观察[J].中国误诊学杂志,2006,6(1):112-112. 被引量：3
-
2吴强,杨永曜,李隆贵,杨天和,蔡运昌,蒋清安.过氧化物酶体增殖物激活型受体α和γ配体对左心室压力超负荷大鼠心肌胶原重塑的影响[J].临床心血管病杂志,2007,23(2):128-131. 被引量：2
-
3王飞,吴强,彭林林,张晓丽,俞杉,梁勤,黄山,令狐颖,周晓泉.再灌注治疗对心肌梗死患者血清MMP-1、TIMP-1含量和心室重塑的影响[J].贵州医药,2007,31(12):1059-1061. 被引量：2
-
4何生松,徐标,韩春荣.双环醇对小鼠日本血吸虫病心肌组织中TGF-β_1、金属蛋白酶1和Ⅰ、Ⅲ型胶原表达的影响[J].中国人兽共患病学报,2009,25(1):34-37.
-
5陈启明,曹恒昌,范昭,张跃华,朱思奇.洋地黄对急性心肌梗死合并急性心力衰竭的左室重塑及胶原代谢的影响[J].北方药学,2015,12(10):24-25. 被引量：8
二级引证文献15
-
1李丽明,郭洁文,邓志军,符永恒,杨敏,潘竞锵,单綺霞.三七总皂苷改善心肌梗死后心室重构大鼠心功能作用[J].今日药学,2009,19(6):3-5. 被引量：6
-
2贾文斌,贾文敏.海滨疗养因子结合运动对糖尿病患者血清MMP-9和TIMP-1的影响[J].实用医药杂志,2013,30(2):106-108. 被引量：1
-
3杨远君.心脏彩超在心肌梗死中的临床应用分析[J].吉林医学,2014,35(16):3494-3495. 被引量：1
-
4李莉,郭欣桐,崔妍,任亚莉,马宁,李鑫宝,牛培.心力衰竭能量代谢重构及治疗的最新研究进展[J].医学研究与教育,2015,32(4):44-49. 被引量：1
-
5曹冉.急性心肌梗死合并心力衰竭再灌注后早期给予洋地黄治疗的疗效分析[J].中西医结合心血管病电子杂志,2015,3(33):57-58. 被引量：5
-
6林绍霞.洋地黄在早期急性心肌梗死合并心力衰竭再灌注后的应用效果分析[J].右江民族医学院学报,2016,38(4):381-382. 被引量：5
-
7黎德良.老年重症心力衰竭急诊内科治疗临床探索[J].罕少疾病杂志,2016,23(5):15-17. 被引量：4
-
8张国新,张云,李月婷.以呼吸困难为首发症状的急性心肌梗塞60例分析[J].中外医疗,2016,35(34):8-10.
-
9林旭辉,陈子凌.洋地黄不同时期应用对早期急性心肌梗死合并心力衰竭再灌注后的效应分析[J].中国现代医生,2016,54(33):98-100. 被引量：2
-
10张鹏,艾力曼·马合木提,孙娟.心肌能量代谢与慢性心力衰竭心室重构关系及心肌能量代谢药物应用的研究进展[J].中华实用诊断与治疗杂志,2018,32(1):94-97. 被引量：44
-
1张晓丽,吴强,彭林林,黄山,令狐颖,周晓泉.心肌梗死后神经内分泌激活与心脏胶原重塑的研究[J].贵州医药,2008,32(7):581-583.
-
2彭林林,吴强,杨天和,张陈匀,张晓丽,黄山,周晓泉.血运重建术对急性心肌梗死患者心脏胶原重塑的影响[J].贵州医药,2010,34(1):11-13. 被引量：2
-
3彭林林,吴强,杨天和,张陈匀,黄山,周晓泉,张晓丽.急诊与择期血运重建对急性心肌梗死后心脏胶原重塑的影响[J].中国心血管病研究,2009,7(4):259-261. 被引量：6
-
4彭林林,吴强.心血管疾病的胶原重塑及其干预研究[J].心血管病学进展,2007,28(2):312-315. 被引量：7
-
5张晓丽,吴强,彭林林,俞杉,梁勤,黄山.心肌梗死后心脏胶原重塑与心功能的变化[J].贵州医药,2008,32(6):487-489. 被引量：5
-
6张晓丽,吴强,彭林林,黄山.心肌梗死后心脏胶原重塑与血清基质金属蛋白酶及其抑制因子的变化[J].贵州医药,2008,32(11):970-972.
-
7吴强,彭林林,张晓丽,刘相飞,张雪松,张静,俞杉,梁勤.血运重建对急性心肌梗死患者心脏胶原重塑的影响[J].临床心血管病杂志,2008,24(5):369-372. 被引量：2
-
8刘相飞,吴强,张雪松,张静,彭林林,张晓丽,黄山.急诊和择期冠脉动脉介入治疗对急性心肌梗死患者心脏胶原重塑的影响[J].临床荟萃,2008,23(14):999-1002.
-
9朱大林,彭仁秀,王晋明.心肌纤维化与肾素血管紧张素醛固酮系统[J].现代诊断与治疗,2001,12(1):21-23. 被引量：1
-
10刘学会,樊光辉.中医药对慢性心衰神经内分泌和细胞因子影响的研究概述[J].中西医结合心脑血管病杂志,2013,11(7):853-854. 被引量：14
